Title Statements
- Full title :CAPA in the pharmaceutical and biotech industries : how to implement an effective nine step program / by J. Rodriguez.
Edition Statements
- Publication Date:2015.
Publication Statements
- Publisher(s):Woodhead Publishing
- Place of Publication:Oxford
- Language:eng
- Publication Date:2015.
Notes
Previously issued in print: Witney: Biohealthcare, 2011.
The Physical Object
- Description:1 online resource.
Edition Identifiers
- ISBN:9781908818379, 1908818379
- oclc:ocn935679448
- LC Classification:RS189
- Dewey Decimal:615.1900685
Table of Contents
Front Cover; Related titles; CAPA in the Pharmaceutical and Biotech Industries; Copyright; Dedication; Contents; Biography; Preface; Introduction; Corrective and preventive action (CAPA); What is an appropriate CAPA program?; Analyze data for trends; Preventive actions; 1 -- Understanding the FDA's CAPA requirements and regulations; Part I. 21 CFR part 820.100 for medical devices; Part II. 21 CFR Part 211: current good manufacturing practice for finished pharmaceuticals; Part III. The FDA's current inspectional approaches; Review of the quality system inspectional technique: medical devices.
QSIT and CAPAWhat is QSIT?; Part IV. QSIT and CAPA: inspectional objectives; Purpose/importance; Part V. Quality systems approach to pharmaceutical current good manufacturing practice regulation, September 2006; Background; In August 2002, the FDA announced the Pharmaceutical CGMPs for the Twenty-First Century Initiative; CGMPs and the concepts of modern quality systems; Review of the concept of corrective action; Preventive actions; Promote improvement; Part VI. ISO 13485 and CAPA: inspectional objectives; Measurement, analysis, and improvement; General; Monitoring and measurement.
(Custome…
Subjects
Writers
More from this Series
No reviews yet. Be the first to rate this work.
Files & Downloads
-
CAPA in the Pharmaceutical and Biotech Industries…
PDF · 3.5 MB · updated
Rate & Review